Monica Red-Brewer
Vanderbilt University(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Monoclonal and Polyclonal Antibodies Research, PI3K/AKT/mTOR signaling in cancer, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer(2014)266 cited
- → Functional Effects of Glycosylation at Asn-579 of the Epidermal Growth Factor Receptor(2005)76 cited
- → Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting(2021)68 cited
- → An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression(2017)43 cited
- → LYN-activating mutations mediate antiestrogen resistance in estrogen receptor–positive breast cancer(2014)40 cited
- → Abstract 867: EGFR kinase domain duplication (EGFR-KDD) is activated by asymmetric intra-molecular dimerization(2019)
- → Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer(2025)
- → Abstract P6-12-09: Pan-HER, an antibody mixture with antitumor activity against drug-resistant HER2-overexpressing breast cancers with high ERBB ligand expression(2017)